2011 Annual Meeting | Diagnostic Testing in Neuromuscular Disease

Date Saturday 04/09/11

Time 04:00 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Kick-Off Program

Director(s) Yadollah Harati, MD, FAAN

Topic(s)

Learning Objectives Participant should be familiar with the proper utlization of tests in the work-up of certain neuromuscular disorders.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist

Teaching Styles Didactic

Event Timeline
04:00 PM - 05:00 PM		Testing for Muscle and Motor Neuron Disorders Yadollah Harati, MD, FAAN
04:00 PM - 06:00 PM		Break
05:00 PM - 06:00 PM		Testing for Peripheral Neuropathies and Disorders of Neuromuscular Junction Gil I. Wolfe, MD, FAAN

Faculty Disclosures
Yadollah Harati, MD, FAAN	No disclosure on file
Gil I. Wolfe, MD, FAAN	Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from Immunovant. The institution of Dr. Wolfe has received research support from Roche. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies.

��ɫ����